This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Tsubota Laboratory, Inc.. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (2018)
- Meguro-ku, JP (2020)
Company Filing History:
Years Active: 2018-2020
Title: Kazuno Negishi: Innovator in Myopia Treatment and Prevention
Introduction
Kazuno Negishi is a notable inventor based in Meguro-ku, Japan. He has made significant contributions to the field of myopia treatment and prevention through his innovative devices. With a total of two patents to his name, Negishi is dedicated to addressing the challenges associated with myopia.
Latest Patents
Negishi's latest patents include a myopia treatment device and a myopia prevention device. The myopia treatment device aims to provide a solution for individuals suffering from myopia. It features a light transmission part that can be selected from various tools, such as eyesight correcting tools and light sources. This device transmits violet light with a wavelength ranging from 360 nm to 400 nm, effectively treating myopia. Additionally, the myopia prevention device is designed to suppress the occurrence and progression of myopia. It also includes a light transmission part that transmits light within a wavelength range of 350 nm to 400 nm, helping to prevent myopia.
Career Highlights
Kazuno Negishi is associated with Tsubota Laboratory, Inc., where he continues to develop innovative solutions for vision-related issues. His work focuses on creating devices that utilize specific wavelengths of light to improve eye health.
Collaborations
Negishi collaborates with esteemed colleagues, including Kazuo Tsubota and Hidemasa Torii, who contribute to the research and development of his inventions.
Conclusion
Kazuno Negishi's work in myopia treatment and prevention showcases his commitment to advancing eye care technology. His innovative devices have the potential to significantly impact the lives of those affected by myopia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile